Mouhannad Jumaa

Title: The Innovative Contributions of Mouhannad Jumaa

Introduction

Mouhannad Jumaa is a notable inventor based in Foster City, CA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of methods that enhance the solubility and stability of peptide proteasome inhibitors. With a total of 2 patents to his name, Jumaa's work is paving the way for advancements in drug delivery systems.

Latest Patents

One of his latest patents is focused on "Cyclodextrin complexation methods for formulating peptide proteasome inhibitors." This disclosure provides methods for formulating compositions that include one or more peptide proteasome inhibitors and a cyclodextrin, particularly a substituted cyclodextrin. These methods significantly increase the solubility and stability of proteasome inhibitors, facilitating their manufacture and administration. For instance, homogeneous solutions of carfilzomib can be achieved at a pharmaceutically useful pH and at higher concentrations than previously possible.

Another important patent is for "Modified release formulations for oprozomib." This disclosure features modified release pharmaceutical formulations that are useful for the oral administration of oprozomib, or a pharmaceutically acceptable salt thereof. The patent outlines methods of making and using these formulations, which are designed to improve the delivery of the drug to human or animal subjects.

Career Highlights

Mouhannad Jumaa is currently employed at Onyx Therapeutics, Inc., where he continues to innovate in the field of pharmaceutical sciences. His work is characterized by a commitment to improving drug formulations and enhancing patient outcomes.

Collaborations

Throughout his career, Jumaa has collaborated with notable colleagues such as Evan Lewis and Peter Shwonek. These partnerships have contributed to the successful development of his patented technologies.

Conclusion

Mouhannad Jumaa's contributions to pharmaceutical formulations demonstrate his innovative spirit and dedication to improving drug delivery systems. His patents reflect a deep understanding of complex chemical interactions and a commitment to advancing medical science.